Gossamer Bio, Inc. (GOSS) › Shareholders' EquityGossamer Bio, Inc. (GOSS) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2016: -$123.0K2017: -$6.86M2018: -$120.07M2019: $352.49M2020: $320.68M2021: $121.46M2022: $12.08M2023: $62.77M2024: $29.49M2025: -$122.76M-$122.76M2016Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$122.76M-516.2%2024$29.49M-53.0%2023$62.77M+419.7%2022$12.08M-90.1%2021$121.46M-62.1%2020$320.68M-9.0%2019$352.49M+393.6%2018-$120.07M-1649.8%2017-$6.86M-5478.9%2016-$123.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share